Latest market research report titled Bio Pharma Market in India 2017 states that while historically the biopharmaceuticals market in the country grew at a CAGR of 15.7%, it is expected to grow at a CAGR of 13.6% between 2016 and 2022.
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. The cancer supportive care market is forecast to grow from $11.7 billion in 2015 to $12.4 billion in 2022, at a compound annual growth rate of 0.9%.